Menu

Michael PELLERIAUX

MARIN

En résumé

STUDY MANAGER


7 YEARS EXPERIENCED IN CLINICAL RESEARCH

Over 3 years of international clinical research experience in pharmaceutical companies as study manager for Bayer Shering Pharma, insourced by Hays Pharma

A 1.5 year of international clinical research experience in pharmaceutical companies as local project manager

A 2.5 years experienced in International CRO Chiltern as CRA

Phases II, III, IV, observational studies
Specialties
Oncology
growth hormone
diabetes (type I & II)

Mes compétences :
project manager
clinical research

Entreprises

  • Celgene International R&D Switzerland - Study Manager

    2011 - maintenant
  • Hays Pharma - Study Manager for Bayer Shering Pharma

    Paris 2008 - 2011 International project manager / STUDY MANAGER in BAYER SCHERING PHARMA– (59)
     Study start up and study execution for an outsourced Oncology Phase III study, breast cancer, International, 560 patients, 23 countries, 100 sites
     Study start up and study execution for an Oncology Phase II study, ovarian cancer, International, 240 patients, 14 countries, 70 sites
     Study start up and study execution for an outsourced Oncology Phase III study, gastro intestinal tumor, International, 170 patients, 18 countries, 85 sites
     Study start up phase for an outsourced Diagnostic Imaging Phase IV study, International, 1000 patients, 11 countries, 80 sites
     Study start up phase for a Diagnostic Imaging Phase III study, International, 400 patients, 13 countries, 80 sites
     Support for external suppliers management (IVRS, central lab, central reading) for an Oncology Phase III study, lung cancer, International, 900 patients, 20 countries, 90 sites


    Key areas of Responsibility:
     Management of countries (in Asia Pacific region, in the American region and in Europe)
    International conferences
     Development of the core study documents including: study protocol, patient information and informed consent, study synopsis, study booklet, eCRF, Study Monitoring Plan, Drug packaging plan, eCRF completion guidelines, newsletters, DMC charter.
     Development of the total study budget, for providing monthly/yearly estimates and tracking study budget
     Management of operational study feasibility conducted by country and study timelines, milestones, enrollment plan development.
     Lead and management of a cross functional Study Team (approx 25 persons)
     Study Management and study tracking to ensure ongoing study activities, study execution and timelines (patient enrollment, data cleaning progress and overall study progress).
     Training plan strategy development for the study team (monitors, local project manager) and site personnel.
     Responsible for planning and conducting investigators meeting (in US, EU and AP region)
     For outsourcing strategy or outsourced activities:
    o Selection process for the external supplier/CRO (request for proposal, bid defense, kick of meeting) and development of a master signed agreement.
    o Definition of the outsourced tasks
    o Budget tracking, change orders
    o Development of training plan for the external suppliers
    o External suppliers / CRO management
    o Oversight management
  • Novo Nordisk - Local Trial Manager

    La Défense Cedex 2006 - 2008 Set up and coordination of a local pediatric phase IV study in type 1 diabetes,of a phase IV study in type 2 diabetes (france, UK).
    Set up and coordination of an observational study in growth hormone therapy (pediatrics)and of bservational studies in type 2 diabetes.
    Local coordination of an outsourced international phase III study in growth hormone therapy

    Key area of responsability :
    • Plan, manage and execute study (France, UK)
    • External suppliers and budget management (external suppliers selection, contact negociation, kick off meeting, contract agreement and contract amendment)(CRO, central lab, local depot)
    • Plan, facilitate and lead study team meetings (teleconference, face to face meeting)
    • Create and drive study level timelines
    • Review and validation of the site feasibility reports, site initiation reports and monitoring reports
    • Develop study level enrolment plan and enrolment projections
    • Writing and review of the study documents (protocol, synopsis, inform consent, CRF, patient diary, newsletters)
    • Regulatory submissions
    • Super user of a clinical trial management software (IMPACT)
    • Sponsor Trial Master File
  • Chiltern International - CRA

    Slough 2003 - 2006 CRA activities for :
    **International phase III study in endocrinology (hypogonadism and metabolic symdrome) –Management of 5 centres in France and 2 centres in Belgium.
    **International phase III study in urology –Management of 5 centres in France.
    **International phase III study in Type 2 diabetes – Management of 35 centres in France

    Key area of responsability :
    Feasibility, pre-study visits, initiation visits, monitoring visits and close-out visits
    Creation of study documents: Synopsis, inform consent, financial contracts
    Participation in teleconferences (weekly tracking, monthly reports)
    Initial and additional submissions to Ethic Committees (France & Belgium)and Health Authorities
    Administrative and financial follow-up
    Creation and submission of financial agreement template (Investigator, Hospital…)
    Study drug management (IVRS system)
    Audit

Formations

Réseau

Annuaire des membres :